Alexander Fleming: life and legacy
Life and career
Fleming observed in 1928 that a Penicillium mould inhibited staphylococci, but he could not turn the finding into a stable medicine. Howard Florey, Ernst Chain and a wider team developed purification and production methods during the Second World War. The history shows discovery as a collaborative process rather than one accidental moment.
Historical context
Medical innovation depends on patients, laboratories, care workers and systems of production. Discovery should be assessed alongside ethics, access and unintended harm.
Legacy and interpretation
Alexander Fleming's reputation has been shaped by commemoration, political argument and the survival of unequal evidence. A responsible biography compares contemporary records with later interpretation, recognises people affected by their decisions and avoids reducing broad change to one famous life.

.jpg?width=1100)



